Comparison of difloxacin, enoxacin, and cefoperazone for treatment of experimental Enterobacter aerogenes endocarditis.
This study compared difloxacin administered orally, enoxacin administered orally, and cefoperazone administered intramuscularly for the treatment of experimental Enterobacter aerogenes endocarditis. Difloxacin significantly reduced bacterial counts of vegetations, as compared with enoxacin and cefoperazone. Enoxacin and cefoperazone did not differ significantly. This study demonstrated that difloxacin was significantly more effective than enoxacin and cefoperazone for the treatment of E. aerogenes endocarditis in rabbits.
Boscia
J A
JA
Kobasa
W D
WD
Kaye
D
D
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002438:Cefoperazone / Q000097:blood / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D015365:Enoxacin; D004754:Enterobacter / Q000187:drug effects; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D005260:Female; D024841:Fluoroquinolones; D009287:Naphthyridines / Q000097:blood / Q000627:therapeutic use*; D011817:Rabbits
D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D009287:Naphthyridines; D015365:Enoxacin; D002939:Ciprofloxacin; C047225:difloxacin; D002438:Cefoperazone